4//SEC Filing
Perkins Adelene Q 4
Accession 0000899243-20-001080
CIK 0001113148other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:00 PM ET
Size
8.5 KB
Accession
0000899243-20-001080
Insider Transaction Report
Form 4
Perkins Adelene Q
Pres & Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2020-01-10+606,250→ 606,250 totalExercise: $1.25Exp: 2030-01-10→ Common Stock (606,250 underlying) - Award
Common Stock
2020-01-10+155,134→ 793,190 total
Holdings
- 16,446.79(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]Represents the reporting person's 2019 contingent compensation award paid in shares of common stock in lieu of cash at the election of the Compensation Committee of the issuer's Board of Directors.
- [F2]Includes 10,593 shares of common stock acquired by the reporting person on June 14, 2019 and 10,593 shares of common stock acquired by the reporting person on December 13, 2019 through participation in the issuer's Employee Stock Purchase Plan.
- [F3]The option vests as to 1/48th of the shares on January 31, 2020 and vests as to 1/48th of the shares at the end of each calendar month thereafter.
Documents
Issuer
INFINITY PHARMACEUTICALS, INC.
CIK 0001113148
Entity typeother
Related Parties
1- filerCIK 0001375124
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 5:00 PM ET
- Size
- 8.5 KB